Pengjun Zhang

Title: Pengjun Zhang and a Novel Tumor-Imaging Probe

Introduction

Pengjun Zhang is an inventor associated with Nanjing, China, and Nanjing Nuoyuan Medical Devices Co., Ltd. His listed patent work concerns a technetium-99m-labeled probe designed to support tumor diagnosis.

Latest Patents

Zhang is named on one patent: “Brand-new skeleton 99MTC-FAPI diagnostic probe and use thereof in preparation of drug or reagent for diagnosing tumors.” The disclosure describes a dimeric compound targeting fibroblast activation protein (FAP), labeled with technetium-99m. It reports that, compared with conventional FAP inhibitor radiopharmaceuticals, the novel-skeleton dimeric compound has high tumor uptake, strong contrast between tumor and background, and favorable biodistribution in vivo. The patent proposes its use in preparing a drug or reagent for diagnosing tumors.

Career Highlights

The available information connects Zhang’s patent activity with Nanjing Nuoyuan Medical Devices Co., Ltd. His listed invention focuses on molecular imaging and the development of diagnostic agents for tumors.

Collaborations

Yueqing Gu and Yang Luo are identified as Zhang’s coworkers. They are also associated with the patent work described here.

Conclusion

Pengjun Zhang’s listed invention explores a technetium-99m-labeled FAP-targeting probe intended to improve tumor imaging through high uptake, clear tumor-to-background contrast, and favorable in-vivo distribution.